Skip to content
  • ABOUT
    • MISSION HISTORY
    • DIRECTORS/STAFF
    • Support
    • Contact Us
    • FAQ’S
    • FINANCIAL INFORMATION
  • WASTEWATCHER
  • MEDIA
    • CONGRESSIONAL RATINGS
    • PORKER OF THE MONTH
    • COMMENTARY
    • PRESS RELEASES
  • LEGISLATIVE
    • Communications to the States
    • Communications to Congress
    • Coalition Letters
    • Testimony
  • GET INVOLVED
    • Action Alerts
    • Support
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Biopharmaceuticals

Biopharmaceuticals, Healthcare, Intellectual Property, Pharmaceuticals

Vote NO on AB 215 – Pharmaceutical – Nevada

03/23/2017 Thomas Schatz

Nevada State Assembly 401 South Carson Street Carson City, Nevada  89701-4747 Dear Assembly Member, AB 215, a so-called pharmaceutical price transparency bill, was introduced on February 13, 2017 and is currently being considered by the Assembly Committee on Health and Human Services.  It would require pharmaceutical companies to provide to the Division of Insurance an […]

340B, Biopharmaceuticals, General Waste, Healthcare

What is the 340B Program and Why You Need to Care

05/15/2014 Elizabeth Wright

Problems in the 340B drug discount program are growing and costs are increasing due as more entities participate in the program.

Posts pagination

Previous 1 2

Search

Council for Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

  • MISSION HISTORY
  • DIRECTORS/STAFF
  • SUPPORT
  • FINANCIAL INFORMATION
  • CONTACT US
  • CAGW
  • 1-800-USA-DEBT ®
  • media@ccagw.org
  • 317 MASSACHUSETTS AVENUE, N.E.
    SUITE 300
    WASHINGTON, D.C. 20002

© Council for Citizens Against Government Waste